[Growth hormone treatment of men with reduced sperm quality].
We have treated two groups of infertile men with growth hormone (GH), namely nine oligozoospermic (< 5 x 10(6) sperm/mL) males and nine asthenozoospermic (percentage mobile sperm < 30 and > 15 x 10(6) sperm/mL) males. The patient groups had a significantly lower GH response to an arginine GH stimulation test as compared to a control group. Each patient was treated with GH for 12 weeks and followed for a total of 36 weeks with sampling of blood and semen. Sperm motility increased significantly during GH treatment in both patient groups. There was no difference in sperm count during the treatment. There were three pregnancies in the nine couples from the asthenozoospermic group and no pregnancies in the oligozoospermic group. Furthermore, we found that seminal plasma IGF-I increased simultaneously with the increase in sperm motility. These data suggest that GH stimulates IGF-I production from Sertoli and/or Leydig cells, which in a paracrine/autocrine manner stimulates maturation of spermatozoa with subsequent increased sperm motility.
Ovesen
P G
PG
Arhus Universitetshospital, Skejby Sygehus, gynaekologisk obstetrisk afdeling.
Jørgensen
J O
JO
Ingerslev
J
J
Orskov
H
H
Christiansen
J S
JS
D000328:Adult; D013006:Growth Hormone / Q000008:administration & dosage*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis; D008297:Male; D009845:Oligospermia / Q000188:drug therapy*; D011446:Prospective Studies; D013079:Sperm Maturation / Q000187:drug effects; D013081:Sperm Motility / Q000187:drug effects*; D013091:Spermatogenesis / Q000187:drug effects
D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone
Vaeksthormonbehandling af maend med nedsat saedkvalitet.